Overview
BioRegenx, Inc. is redefining health intelligence with new patented technologies and artificial intelligence. We specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. Our primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.
The current asset portfolio includes:
- First-to-market, clinically relevant, patented technology for monitoring the endothelial glycocalyx and microvascular system.
- A proprietary, patented formula that improves and protects the endothelial glycocalyx.
- Artificial intelligence technology that enables contactless monitoring of vital health in just seconds.
Who We Are
Three patented technologies and solutions include:
- GlycoCheck™: High-definition video imaging analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology. Over 115 studies published.
- Endocalyx Pro™: An all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies.
- DocSun™: Artificial Intelligence using three advanced facial recognition technologies that analyze 21 vital signs and health indicators without physical contact. Also used in private and public transportation.